NCT04310150View on ClinicalTrials.gov

Collagen-thrombin Matrix Efficacy During Cardiac Surgery: a Prospective Randomized Controlled Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

March 17, 2020

Study Completion Date

March 31, 2020

Conditions
Coronary Artery Disease
Interventions
DRUG

Collastat

hemostatic agent that combine porcine-derived collagen thrombin

DEVICE

Floseal

hemostatic agent that combine bovine-derived gelatin

Trial Locations (1)

Unknown

Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT04310150 - Collagen-thrombin Matrix Efficacy During Cardiac Surgery: a Prospective Randomized Controlled Trial | Biotech Hunter | Biotech Hunter